Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 135)
Posted On: 07/05/2017 6:04:22 PM
Post# of 72446
Avatar
Posted By: sox0407
Dow's Merck Stumbles After FDA Puts Keytruda Trials On Hold

Dow component Merck (MRK) stock toppled late Wednesday after the Food and Drug Administration put three clinical trials on hold involving the drugmaker's immuno-oncology med, Keytruda, in a blood cancer known as multiple myeloma.

Trials of Keytruda and low-dose Dexamethasone combined with either Pomalyst or Revlimid, from Celgene (CELG), were placed on full clinical holds. Another similar combination study was placed on a partial clinical hold.

Last month, Merck paused enrollment in two of those trials after more patients receiving Keytruda died. On Wednesday, the FDA said the risks of those combinations outweighed the potential benefits.

In after-hours trading on the stock market today, Merck stock was off an additional 1%, near 63.50. It ended the regular trading session down a fraction, to 64.16. Shares have been forming a flat base since early March. Merck is one of three biopharmaceutical companies on the Dow Jones industrial average.

http://www.investors.com/news/technology/dows...s-on-hold/













(0)
(0)






Dont-give-up.jpg



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site